New Key Statistics Module, Z-Score and F-Score
OTCPK:ASPHF Key Ratios
| Market Cap $ M | 1,747.38 |
| Enterprise Value $ M | 1,830.16 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 16.00 |
| Price/Sales | 12.73 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 124.00 |
| EPS (TTM) $ | -0.18 |
| Beneish M-Score | -1.6 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 3.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -43.41 |
| EV-to-EBITDA | -47.45 |
| PEG | -- |
| Shares Outstanding M | 315.20 |
| Net Margin (%) | -40.77 |
| Operating Margin % | -36.92 |
| Pre-tax Margin (%) | -41.90 |
| Quick Ratio | 1.83 |
| Current Ratio | 1.84 |
| ROA % (ttm) | -12.84 |
| ROE % (ttm) | -77.50 |
| ROIC % (ttm) | -18.02 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.84 |
ASPHF Number of Guru Trades
ASPHF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ASPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ASPHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ascentage Pharma Group International Insider Transactions
No Available Data
News about OTCPK:ASPHF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers